Targeting the NLRP3 inflammasome in cardiovascular diseases

S Toldo, E Mezzaroma, LF Buckley, N Potere… - Pharmacology & …, 2022 - Elsevier
The NACHT, leucine-rich repeat (LRR), and pyrin domain (PYD)-containing protein 3
(NLRP3) inflammasome is an intracellular sensing protein complex that plays a major role in …

An overview and update on obesity and the obesity paradox in cardiovascular diseases

A Elagizi, S Kachur, CJ Lavie, S Carbone… - Progress in …, 2018 - Elsevier
Obesity increases a number of cardiovascular disease (CVD) risk factors, but patients with
many types of CVD may have a better prognosis if classified as overweight or obese, a …

The NLRP3 inflammasome in acute myocardial infarction

S Toldo, A Abbate - Nature Reviews Cardiology, 2018 - nature.com
The heart is extremely sensitive to ischaemic injury. During an acute myocardial infarction
(AMI) event, the injury is initially caused by reduced blood supply to the tissues, which is …

Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury

S Toldo, AG Mauro, Z Cutter… - American Journal of …, 2018 - journals.physiology.org
Myocardial ischemia-reperfusion injury induces a sterile inflammatory response, leading to
further injury that contributes to the final infarct size. Locally released danger-associated …

Inflammation in human heart failure: major mediators and therapeutic targets

M Reina-Couto, P Pereira-Terra… - Frontiers in …, 2021 - frontiersin.org
Inflammation has been recognized as a major pathophysiological contributor to the entire
spectrum of human heart failure (HF), including HF with reduced ejection fraction, HF with …

The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction

GPJ Van Hout, L Bosch, GHJM Ellenbroek… - European heart …, 2017 - academic.oup.com
Aims Myocardial infarction (MI) triggers an intense inflammatory response that is associated
with infarct expansion and is detrimental for cardiac function. Interleukin (IL)-1β and IL-18 …

IL-18 cleavage triggers cardiac inflammation and fibrosis upon β-adrenergic insult

H Xiao, H Li, JJ Wang, JS Zhang, J Shen… - European heart …, 2018 - academic.oup.com
Aims Rapid over-activation of β-adrenergic receptor (β-AR) upon stress leads to cardiac
inflammation, a prevailing factor that underlies heart injury. However, mechanisms by which …

Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society

L Zanoli, M Briet, JP Empana, PG Cunha… - Journal of …, 2020 - journals.lww.com
Inflammation is a physiological response to aggression of pathogenic agents aimed at
eliminating the aggressor agent and promoting healing. Excessive inflammation, however …

Obesity and heart failure: focus on the obesity paradox

S Carbone, CJ Lavie, R Arena - Mayo Clinic Proceedings, 2017 - Elsevier
The escalating prevalence of obesity has been linked to substantial increases in both
metabolic and cardiovascular disease. Nevertheless, the direct effects of obesity on …

The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction

R Gao, H Shi, S Chang, Y Gao, X Li, C Lv… - International …, 2019 - Elsevier
Abstract Background/Aims. Early inflammatory responses after myocardial infarction (MI) are
likely to increase myocardial fibrosis and subsequent cardiac remodeling. MCC950, a …